Posts Tagged ‘India’

Reading List 8/31/2010

August 31st, 2010

A new list of reads for your reading pleasure! Today we’re reading about a successful experimental treatment for victims of trachoma, the current state of global immunization, the spread of trachoma within the Northern Bahr el Ghazal region of Sudan, and Lymphatic filariasis in India.

Experimental vision cure proves successful, Thomas H. Maugh, Los Angeles Times
Global immunizations hit record but miss millions, David Morgan, Reuters
Mystery eye disease spreads across Northern Bahr el Ghazal, Ngor Arol Garang, Sudan Tribune
Lymphatic filariasis in India: Epidemiology and control measures, S Sabesan, P Vanamail, KHK Raju, P Jambulingam, Journal of Postgraduate Medicine

A Closer Look at Mass Drug Administration

July 15th, 2010

By: Alanna Shaikh

Photo Courtesy of http://www.doh.gov.ph

One of the most effective ways of fighting Neglected Tropical Diseases is through Mass Drug Administration (MDA). Basically, you treat an entire population with the drug for a specific disease. The idea is that by treating everybody at once, you interrupt transmission of the disease. So you get the benefit of treatment for all the individuals involved, and you also put a major dent into the spread of the disease. (If you want to learn more about MDA, there is a good article by Peter Hotez.)

The tricky thing about doing mass administration is that it’s an awful lot of people you need consent from. As soon as people start refusing the treatment – not taking the drugs, avoiding the treatment site, keeping their kids home from school, whatever – then your drug administration isn’t so mass any more. The people who get treated still benefit but you lose the multiplier effect of getting the whole population at once. In a worst case scenario, people do partial treatments. Then there is no individual benefit, no mass treatment benefit, and you run the risk of causing resistance to the drug treatment.

» Read more: A Closer Look at Mass Drug Administration

Reading List 6/30/2010

June 30th, 2010

New list of reads to help get you through the week! Today we’re reading about great strides and advances in the control and elimination of NTDs – such as the substantial drop in human African trypanosomiasis cases over the last five decades – as well as other developments that pose more as obstacles, such as the re-emergence of Dengue in the U.S. Take a look:

Human African trypanosomiasis: number of new cases drops to lowest level in 50 years, WHO
Community-Based Education Strengthens Elimination of Lymphatic Filariasis, Science Daily
Pharmacy students work to close the gap, Charles Sturt University
Foreign Policy Examines GHI, PEPFAR, Kaiser Family Foundation
Researchers In Australia Make Important Malaria Breakthrough, Government of Australia
Do Parasites Make You Dumber?, Cassandra Willyard, ScienceNOW
Dengue Re-emerges in U.S., Spurring Race for Vaccine, Gayathri Vaidyanathan, The New York Times

Policy Update – Global Health Council 2010 Conference

June 22nd, 2010

Last week, the Global Health Council (GHC) held its 37th annual international conference in Washington, DC. It was a well attended event filled with participants from across the globe and the global health community. Dozens of panel discussions, plenary sessions, special events, films, and exhibits were all available to provide attendees with valuable venues for learning, networking, and engaging in substantive global health conversations.

Topics ranged from global health metrics and the Millennium Development Goals to maternal and child health, HIV/AIDS, chronic and degenerative diseases (including NTDs), and financing mechanisms. Additionally, GHC designed two tracks for those in the policy or research arenas highlighting subjects of particular interest for these respective groups. As the new policy director for the Global Network for Neglected Tropical Diseases, I closely followed the policy track attending sessions on the budget landscape, advocacy, countdown to 2015, U.S. and multilateral organizations, and the use of global health as a diplomacy tool. The broader plenary sessions also provided updates and direct interaction with current leaders in the global health space—all timely and useful information.

Throughout the week, conferees were easily identified by their cotton satchels holding programs and conference materials. These bags were handmade by women in Chennai, India who are part of the Pi Project—a non-profit organization that provides economic empowerment to vulnerable women. Profits from the bag sales went directly to the women involved in the project. The satchels were a constant reminder of why global health advocates, thought leaders, and stakeholders gathered to meet in Washington, and who the real beneficiaries truly are.

Michelle Brooks joined the Global Network for Neglected Tropical Diseases as its new policy director in February 2010. She previously worked for the U.S. Peace Corps and World Vision.

Reading List 5/17/2010

May 17th, 2010

A great list of new reads! Today we’re reading about the distribution of trachoma treatment amongst indigenous communities in Australia, a protein (arrestin) found in worms that could potentially help the fight against cancer, along with a series of articles on vaccines – particularly the challenges that public health professionals face in providing access to vaccines in low-income countries, The All India Drug Action Network’s push for the WHO to introduce the pneumococcal (Hib) vaccine to Asian countries, and how worms are having an adverse impact on vaccine efficacy in swine.

Eye care boost for Indigenous communities, Australian Healthcare and Hospital Association
New protein found that controls longevity — in roundworms, MTB Europe
Report Examines Vaccine Costs, Access In Low-Income Countries, Medical News Today
AIDAN push for the WHO to introduce Hib vaccine, Gireesh Babu, PharmaBiz
Worm infections and M.hyo vaccine efficacy in pigs, VetsOnline

Reading List 4/12/10

April 12th, 2010

Happy Monday, everybody. Today we’re reading an article about NTDs in India and an article about how drug companies are working to combat NTDs, amongst other diseases.

Neglected tropical diseases afflict millions in India, Narayan Lakshman, The Hindu
Drug giants tackle ‘neglected’ effort, Thomas Kupper, San Diego Union-Tribune

Reading List – 3/9/2010

March 9th, 2010

Hello everybody! Today we’re reading about GlaxoSmithKline upping its efforts to fight lymphatic filariasis, a new treatment for American soldiers who caught cutaneous leishmaniasis in Iraq, the latest release on the fight against LF in India, and, on a different note, a group of ultra-Orthodox rabbis declaring that lox should no longer be considered kosher due to a variant of roundworm found in fish.

In tough climate, GSK dedicates plant to fight elephantiasis, Rick Smith, Localtechwire

Heat therapy shown effective in treating cutaneous leishmaniasis among US soldiers in Iraq, PLoS Neglected Tropical Diseases

DMO allays fears over DEC tablets, The Hindu

Rabbis Claim Lox No Longer Kosher, Erica Butler, NBC New York

Dr. Thomas Cherian, Pneumonia Expert, Honored for Efforts to Reduce Deaths from Preventable and Treatable Diseases

February 4th, 2010
Dr. Cherian recieving the PACE Global Leadership Award
Dr. Cherian recieving the PACE Global Leadership Award

On the heels of the Bill & Melinda Gates Foundation’s $10 billion commitment to fund vaccine research, development and delivery throughout the developing world, a leading pneumonia expert, Dr. Thomas Cherian of the World Health Organization (WHO), was honored Monday in Geneva for his efforts to accelerate access to vaccines preventing pneumococcal disease, the world’s leading vaccine-preventable killer of children under age five.

Over the course of a 25-year career that began at the Christian Medical College in Tamil Nadu, India, Dr. Cherian, who currently serves as coordinator of the Expanded Programme on Immunization at the WHO, has made significant contributions and remained committed to fighting pneumonia and pneumococcal diseases.  Last year, he led efforts to produce the first-ever country-by-country estimates of pneumococcal disease burden. This work found that in India, for example, more than 140,000 children die each year of pneumococcal disease — approximately one child every four minutes in India alone.

Dr. Cherian received the Pneumococcal Awareness Council of Expert’s (PACE) Global Leadership Award, which recognizes an individual, organization or country that has championed pneumococcal disease prevention and made a significant contribution towards policies that advance the introduction of pneumococcal conjugate vaccines.  Pneumococcal disease is a leading cause of pneumonia which kills an estimated 2 million children under age five each year.

The contributions of individuals to the health field are not always publicized but it’s the efforts of individuals like Dr. Cherian that add to the collective goal of reducing deaths from preventable and treatable diseases, whether infectious or neglected.

The Global Network and PACE are initiatives of the Sabin Vaccine Institute, whose mission is to reduce needless human suffering from infectious and neglected tropical diseases.